Aryavan Enterprise Ltd

Capital action: Preferential issue of equity warrants

• Proposal to issue 23,90,000 equity warrants on a preferential basis.
• Warrants issued for cash; one equity share per warrant on exercise.
• Aggregate issue up to ₹2.39 crore; price to be determined per ICDR rules.
• Subject to regulatory and shareholders' approvals; may be via EGM/AGM.
• Exercise window: 18 months from allotment.
• 18 investors across promoter and non-promoter/public categories.
• Post-allotment price to be determined under pricing guidelines.
• Conversion requires payment of full warrant price.
• Annexure-B discloses promoter and non-promoter allocations totaling 23,90,000 warrants.

Financial results approved

• Approved unaudited Standalone and Consolidated results for quarter ended 30 June 2026.
• Results prepared under IND AS; single operating segment; no segment disclosures.

Audit report status

• Audit report by S N D K & Associates LLP taken on record; unmodified opinion.

Standalone highlights

• Standalone Q1 revenue from operations: 1,183.40 Lakhs; total income: 1,233.62 Lakhs.
• Standalone PAT: 58.29 Lakhs; EPS (continuing): Basic 0.84, Diluted 0.84.

Consolidated highlights

• Consolidated Q1 total income: 1,634.50 Lakhs; PAT: 58.53 Lakhs.
• Owner's share of PAT: 58.29 Lakhs; subsidiary profit: 0.24 Lakhs; EPS: Basic 0.84, Diluted 0.84.

Subsidiaries and notes

• Consolidated results include Padmavati Chemicals subsidiary; figures provided by management.

Meeting Details

• Date: 13 August 2026; Time not disclosed; at Registered Office, 308 Shital Varsha Arcade, Ahmedabad.

Key Agenda Items

• Unaudited standalone and consolidated financial results for Q1 ended 30 June 2026, with Limited Review Report.
• Any other business with the Chair's permission.

Other Notes

• Trading window closure periods not specified.

Aryavan Enterprise Ltd: Trading Window Closure from 01 July 2026 until 48 hours after the declaration of Unaudited Financial Results for the 1st Quarter ended 30 June 2026 (Standalone and Consolidated)

🗓️ Meeting Details

• Board meeting scheduled for Saturday, 14th February 2026.

📊 Financial Performance

• Consider and approve un-audited standalone and consolidated financial results.
• Financial results cover the third quarter and nine months ended 31st December 2025.
• Limited Review Report of Statutory Auditors to be noted.